Guangdong Taienkang Pharmaceutical Co. Ltd Total Liabilities
Guangdong Taienkang Pharmaceutical Co. Ltd total liabilities. Based on the latest financial reports, Guangdong Taienkang Pharmaceutical Co. Ltd (301263) has total liabilities worth CN¥820.32 Million CNY (≈ $120.04 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Guangdong Taienkang Pharmaceutical Co. L to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2025)
Total liabilities of Guangdong Taienkang Pharmaceutical Co. Ltd from 2019 to 2025. This chart illustrates how Guangdong Taienkang Pharmaceutical Co. Ltd's total liabilities have evolved over time, based on quarterly financial data.
Guangdong Taienkang Pharmaceutical Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Guangdong Taienkang Pharmaceutical Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zhe Jiang Dong Ri Ltd Co
SHG:600113
|
China | CN¥803.23 Million |
|
Eurocommercial Properties N.V.
AS:ECMPA
|
Netherlands | €1.96 Billion |
|
Nanobiotix
NASDAQ:NBTX
|
USA | $152.24 Million |
|
SIGMAROC PLC LS -01
F:M2I2
|
Germany | €1.41 Billion |
|
Akr Corporindo Tbk
JK:AKRA
|
Indonesia | Rp22.93 Trillion |
|
Grand Plastic Technology
TWO:3131
|
Taiwan | NT$12.17 Billion |
|
Sanyang Motor Co Ltd
TW:2206
|
Taiwan | NT$55.70 Billion |
|
Siglent Technologies Co Ltd
SHG:688112
|
China | CN¥128.77 Million |
Liability Composition Analysis (2019–2025)
This chart breaks down Guangdong Taienkang Pharmaceutical Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Guangdong Taienkang Pharmaceutical Co. L.
Liquidity & Leverage Metrics
Guangdong Taienkang Pharmaceutical Co. Ltd Total Liabilities Ratios Explained
Guangdong Taienkang Pharmaceutical Co. Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.68 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.50 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Guangdong Taienkang Pharmaceutical Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2025)
The table below shows the annual total liabilities of Guangdong Taienkang Pharmaceutical Co. Ltd from 2019 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥676.07 Million ≈ $98.93 Million |
+36.67% |
| 2024-12-31 | CN¥494.67 Million ≈ $72.39 Million |
+23.75% |
| 2023-12-31 | CN¥399.72 Million ≈ $58.49 Million |
+115.33% |
| 2022-12-31 | CN¥185.63 Million ≈ $27.16 Million |
-19.89% |
| 2021-12-31 | CN¥231.71 Million ≈ $33.91 Million |
-5.47% |
| 2020-12-31 | CN¥245.12 Million ≈ $35.87 Million |
+35.31% |
| 2019-12-31 | CN¥181.16 Million ≈ $26.51 Million |
-- |
About Guangdong Taienkang Pharmaceutical Co. Ltd
Guangdong Taienkang Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company offers various products covering various therapeutic areas, including sexual health medicines, ophthalmic medicines, gastrointestinal medicines, Chinese patent medicines and external medicines, and sanitary materials in the… Read more